This preprint has been withdrawn
Preprint
Review

This version is not peer-reviewed.

Withdrawn: Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review

A peer-reviewed version of this preprint was published in:
Cancers 2025, 17(7), 1235. https://doi.org/10.3390/cancers17071235

Submitted:

09 October 2024

Posted:

10 October 2024

Withdrawn:

17 January 2025

You are already at the latest version

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2026 MDPI (Basel, Switzerland) unless otherwise stated

Accessibility

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings